Výsledky vyhledávání - "Ricardo Notivol"

Akademický článek

A patient preference comparison of Azarga™ (brinzolamide/timolol fixed combination) vs Cosopt® (dorzolamide/timolol fixed combination) in patients with open-angle glaucoma or ocular hypertension

Autor: Thomas K Mundorf, Steven H Rauchman, Robert D Williams, Ricardo Notivol, Brinzolamide/Timolol Preference Study Group

Publikováno v: Clinical Ophthalmology, Vol 2008, Iss Issue 3, Pp 623-628 (2008)

Thomas K Mundorf1, Steven H Rauchman2, Robert D Williams3, Ricardo Notivol4, Brinzolamide/Timolol Preference Study Group51Mundorf Eye Center, Charlotte, NC, USA; 2North Valley Eye Medical Group, Mission Hills, CA, USA; 3Taustine Eye Center, Louisvill

Externí odkaz: https://doaj.org/article/f37c185eca5344bea2793e78610b3af8

Zobrazit plný text záznamu

Gastric tone determines the sensitivity of the stomach to distention

Autor: Jordi Serra, Benoit Coffin, Juan-R. Malagelada, Fermín Mearin, Fernando Azpiroz, Ricardo Notivol

Publikováno v: Gastroenterology. 108:330-336

Whether meal-related symptoms such as postcibal epigastric fullness and discomfort are caused by hypotonic gastric expansion or gastric hypertension is unknown. This study investigated whether symptoms in healthy individuals in response to gastric di

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cc19065fcb9cee96a53579ad11414a28
https://doi.org/10.1016/0016-5085(95)90057-8

Zobrazit plný text záznamu

Treatment of Chronic Nonbacterial Conjunctivitis With a Cyclo-oxygenase Inhibitor or a Corticosteroid

Autor: Ricardo Notivol, Miguel Martínez, Michael V.W. Bergamini, null Pranoprofen Study Group

Publikováno v: American Journal of Ophthalmology. 117:651-656

A multicenter, double-masked, parallel-group clinical trial was carried out in 151 patients with moderate to severe chronic conjunctivitis. The study compared the antiinflammatory efficacy and safety of pranoprofen 0.1%, a new cyclo-oxygenase inhibit

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::2c6c1ecc8180b823ac64361fd224961c
https://doi.org/10.1016/s0002-9394(14)70073-x

Zobrazit plný text záznamu

Prophylactic effectiveness of tobramycin-dexamethasone eye drops compared with tobramycin/vehicle eye drops in controlling post-surgical inflammation in cataract patients : prospective, randomised, double-masked, two-arm, parallel-group, placebo-controlled, multicentre study

Autor: Margaret Kennedy, Dina Amin, Anna Whitling, Ricardo Notivol, Paul C. Cockrum, David Wells

Publikováno v: Clinical drug investigation. 24(9)

To demonstrate the superiority of TobraDex((R)) (tobramycin 3 mg/mL, dexamethasone 1 mg/mL) eye drops over Tobrex((R)) (tobramycin 3 mg/mL)/vehicle (placebo) eye drops in the prophylaxis of inflammation after cataract surgery, and to provide addition

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ab62949530c1e517f0ce4c8c79d88822
https://pubmed.ncbi.nlm.nih.gov/17523714

Zobrazit plný text záznamu

Comparison of topical tobramycin-dexamethasone with dexamethasone-neomycin-polymyxin and neomycin-polymyxin-gramicidin for control of inflammation after cataract surgery: results of a multicenter, prospective, three-arm, randomized, double-masked, controlled, parallel-group study

Autor: Margaret Kennedy, Donata Bertin, Ricardo Notivol, Anna Whitling, Dina Amin, Paul Cockrum

Publikováno v: Clinical therapeutics. 26(8)

Intraocular inflammation is typically treated with a combination of anti-inflammatory and anti-infective drugs. Tobramycin-dexamethasone (TD) has not been associated with any serious adverse events, indicating good tolerability.The aims of this study

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::90d00210c7cceff21e537502c55f60a7
https://pubmed.ncbi.nlm.nih.gov/15476908

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání